Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Search results for

  • A New Jersey jury awards more than $4 million to one plaintiff suing Merck, maker of the painkiller Vioxx, which has been linked to heart problems in some patients. Now the jury will hear evidence on whether Merck should face punitive damages. In a separate Vioxx case, the same jury rules against the plaintiff.
  • Harvard University's Lawrence Summers announces that he will resign at the end of the academic year. The move comes a week before the Faculty of Arts and Sciences was expected to take a second no-confidence vote on Summers, who has been criticized for his abrasive personality and intemperate remarks.
  • Actor, comedian, composer and musician Michael McKean is best known for co-starring in the spoofs This Is Spinal Tap, Best in Show and A Mighty Wind. He is currently co-starring in the Broadway revival of The Pajama Game.
  • Since it was invaded three years ago, Iraq has lost more than $10 billion in oil revenues. Corruption and sabotage are largely to blame. And U.S. and Iraqi officials say insurgents are benefiting. But many say the Oil Ministry's own militia is at the heart of the problem.
  • The world's three most notorious terrorists have all released new tapes within the same week. Experts say it's more likely coincidence than a coordinated message. But some security analysts say the messages of Abu Musab Zarqawi, Osama bin Laden and Ayman al-Zawahiri could imply more than mere rhetoric.
  • New York Times environmental reporter Andrew Revkin has covered climate change and climate politics for 20 years. His new book The North Pole Was Here: Puzzles and Perils at the Top of the World is geared toward young adults.
  • The nation's emergency rooms are crowded and overwhelmed. A major investigation says hospital ERs, which can barely handle daily 911 calls, are far from ready to handle the mass casualties that a flu epidemic or terrorist strike might bring.
  • Supporters of stem-cell research in Missouri have likely turned in enough signatures to place a measure protecting stem-cell research on the ballot. But Sen. Jim Talent (R-MO) has announced he will oppose the measure -- a stance that pro-life groups had long requested.
  • Don't expect a pullout of U.S. troops from Iraq in the near future. An increase in sectarian violence and U.S. dependence on Middle East stability -- largely because of oil-supply concerns -- argue against leaving Iraq.
  • For the first time since the U.S. led the recent invasion of Iraq, the House and Senate are both debating the war. In the House, Democrats are attacking the policies of President Bush, while Republicans are defending them as part of the war on terror.
894 of 29,287